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Abstract
Safer conception strategies to reduce HIV transmission risk include antiretroviral therapy (ART) 
for HIV-positive partners, pre-exposure prophylaxis (PrEP) for HIV-negative partners, condomless 
sex limited to fertile periods, and home-based self-insemination. Resistance to taking treatment or 
cultural concerns may limit uptake of strategies and intervention success. Understanding the 
acceptability and preferences between different approaches is important to optimize service 
delivery. Between February-July 2013, 42 adults (21 HIV-positive and 21 HIV-negative) receiving 
primary care at Witkoppen Health and Welfare Centre in Johannesburg, South Africa, participated 
in focus group discussions or in-depth interviews. Themes were analyzed using a grounded theory 
approach. Acceptability of antiretroviral-based (ARV) strategies varied. Concerns over side 
effects, ARV treatment duration, and beliefs that treatment is only for the sick were common 
barriers, however desperation for a child was noted as a facilitator for uptake. HIV-negative men 
and HIV-positive women had favorable attitudes towards self-insemination, though paternity and 
safety concerns were raised. Self-insemination was generally preferred over PrEP by HIV-negative 
men, and ARV-based strategies were preferred by couples with HIV-negative female partners, 
despite concerns raised about condomless sex while virally suppressed. Knowledge about the 
fertile window was low. A strong counselling component will be required for effective uptake and 
adherence to safer conception services.
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Introduction
Substantial reductions in mother-to-child HIV transmission during pregnancy have been 
achieved in recent years.1, 2 However there is growing awareness of the unmet need for 
services to reduce the risk of horizontal HIV transmission in discordant couples trying to 
conceive.3, 4 Intrauterine insemination or in-vitro fertilization, coupled with sperm-washing 
if the male partner is HIV-infected are strategies used in resource rich settings, but are rarely 
available in Sub-Saharan Africa.5-7 Low cost safer conception strategies, however, can be 
made available globally. These approaches focus on reducing HIV exposure by limiting 
condomless sex to the peri-ovulatory period, or utilizing home-based self-insemination when 
the male partner is HIV-uninfected (also referred to as timed vaginal insemination or manual 
insemination).8 Additionally, antiretroviral-based (ARV) strategies including early initiation 
of antiretroviral therapy (ART) (i.e. prior to the currently recommended CD4 count 
threshold) for the HIV-infected partner or pre-exposure prophylaxis (PrEP) for the 
uninfected partner are gaining importance and may be used separately or in conjunction with 
the non ARV-based strategies.9
Understanding the acceptability and preferences between different approaches is important 
to optimize service delivery. As safer conception services remain largely unavailable in the 
African context,3, 10 little is known about preferences for different strategies among HIV-
affected couples in high burden settings. Previous acceptability studies have either evaluated 
ARV-based strategies for HIV prevention outside of the context of safer conception, or have 
focused on single safer conception methods without comparing the acceptability and 
preferences across methods. For example, manual timed self-insemination was acceptable to 
most Kenyan healthcare providers and patients,11 and most Ugandan couples planning to 
conceive were willing to use condomless intercourse limited to the fertile period.12 Many 
(60%) HIV-infected individuals in discordant relationships participating in a PrEP clinical 
trial in Kenya indicated a willingness to start ART early and 93% of HIV-negative partners 
were willing to use PrEP, however use of methods for safer conception was not explored.13
As part of the design of the safer conception service, Sakh'umndeni,14 we interviewed 
potential clients regarding their knowledge of safer conception methods and assessed the 
acceptability and preferences for different strategies. We also identified potential barriers 
and facilitators for uptake and adherence to safer conception approaches.
Methods
Study design and population
We performed 16 in-depth interviews (IDIs) and four focus group discussions (FGDs, n=42) 
with clients attending primary health care services at Witkoppen Health and Welfare Centre 
(WHWC). WHWC is a primary care clinic that provides services to residents of an informal 
settlement in Northern Johannesburg, South Africa.
Clients attending HIV counseling and testing services and HIV pre-ART or ART care from 
February-July 2013 were purposively sampled and invited to participate. Men and women 
were eligible to participate if they were ≥18 years, desired to have a child in the future, and 
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were either HIV-positive and in a relationship, or HIV-negative and in a relationship with 
someone they knew or believed to be living with HIV. Both individuals in HIV 
seroconcordant and serodiscordant relationships were eligible as safer conception services 
are likely to taken up by both serodiscordant and seroconcordant couples concerned about 
reinfection and/or mother-to-child transmission. Sampling was stratified to ensure 
comparable representation of HIV-positive and negative women and men. FGDs were 
conducted separately according to sex and HIV status. Participants took part in either IDIs or 
FGDs, there was no overlap in participation.
Ethical approval was obtained from the Institutional Review Board at the University of 
North Carolina at Chapel Hill, USA, and the Human Research Ethics Committee at the 
University of the Witwatersrand in Johannesburg, South Africa. All participants completed 
written informed consent.
Data collection and analysis
FGDs and IDIs were semi-structured, using standardized guides, and were led by study team 
members with experience in facilitating qualitative interviews. Questions about acceptability 
and preferences for methods were preceded by a verbal description of what the method 
involves and how to apply it, followed by a discussion to ensure that the participant 
understood. A standardized understanding of methods was ensured through the interview 
guide descriptions. To gain insights on the general societal acceptability of methods and 
potential barriers in the community, FGDs included situational questions that were both 
directly relevant to participants as well as situations that were less relevant (e.g. asking HIV 
positive men about manual self-insemination). Notes, including verbatim quotes, were 
recorded by the study team member and an independent transcriber, and compared 
immediately following the interview to enhance accuracy and completeness. Interviews were 
conducted in English, Zulu or Sotho. Typed notes and transcripts were translated into 
English.
A grounded theory approach was used to examine patterns and emergent themes across the 
transcripts. Categories were identified based on interview guides, and were used to develop 
codes. 15, 16 Two reviewers independently coded each transcript using an iterative process in 
which a codebook of descriptive and interpretive codes was developed, applied, compared, 
discussed, agreed upon, and then repeated iteratively until saturation of emergent themes 
was reached.
Results
IDI and FGD participants included 21 women (12 HIV-positive and 9 HIV-negative) and 21 
men (11 HIV-positive and 10 HIV-negative).
Knowledge of safer conception methods
Participants had generally good knowledge about prevention of mother-to-child transmission 
(PMTCT), but limited understanding of safer conception methods to prevent horizontal 
transmission between partners. Initial responses about safer conception strategies were 
typically limited to knowledge of assisted reproductive technologies and concern about the 
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dangers of condomless sex (Table 1). After probing, participants expressed mixed 
knowledge about ARV-based prevention strategies and very limited knowledge about self-
insemination or timed condomless intercourse.
Acceptability of ARV-based prevention strategies for safer conception
Acceptability of PrEP use among HIV-negative participants varied. Most participants were 
willing to try this method, though concerns regarding side effects were common.
“I don't like ARVs but I would take them for a short period, if they don't treat me 
well I would stop them.” [Female of unknown age, HIV-, 007]
“I would take it. If I didn't like it, if it doesn't suit you, you have to stop. If it causes 
side effects – this is a problem.” [39-year-old male, HIV-, 003]
Still, desperation for a child was perceived by many participants, especially HIV-negative 
women, to be more important than the potential side effects of PrEP.
“I don't mind taking ARVs, I would take them 100%. I can deal with the side 
effects. If you are willing to have a baby, you can have side effects.” [28-year-old 
female, HIV-, 013]
“I'm not afraid of being infected. I started trying for a baby last year without a 
condom and I was put on PEP [post-exposure prophylaxis], but I'm still negative. 
I'm so desperate, everything is fine with me…all I want is a baby.” [Female of 
unknown age, HIV-, 007, who was prescribed ARVs by a nurse for conception 
purposes]
Some HIV-positive participants on ART predicted lower acceptability of treatment for 
uninfected partners.
“I don't think HIV-negative people will take ARVs because they will say they are 
not sick. People taking ARVs are only doing it because they are sick. Most fear the 
side effects these ARVs come with. My partner and I are both taking ARVs, but if I 
was negative there is no way I will take ARVs.” [31-year-old female, HIV+,005]
Participants expressed that treatment duration, lifelong or until pregnant, influences 
acceptability of PrEP.
“As long as it is not a lifetime thing–I could take them until I get pregnant.” 
[Female of unknown age, HIV-, 007]
“She must go for ARVS in the time when she tries to conceive or forever? [If just 
while she tries to conceive] then she could do this.” [Male of unknown age, HIV+, 
016, discordant relationship]
Among the few ART-naïve HIV-positive participants interviewed, earlier ART initiation was 
largely acceptable.
“I only know of pills to prevent infection to the babies, but [if ARVs for the 
infected partner worked as a prevention strategy] I would take ARVs.” [Male of 
unknown age, HIV+, 016]
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Acceptability of non ARV-based strategies for safer conception
Men living with HIV did not perceive home-based self-insemination with a syringe as a 
viable option for discordant couples in which the male partner was HIV-negative. Concerns 
were largely related to a lack of understanding around human reproduction. Thus even 
though participants understood how to perform the self-insemination method, they often 
demonstrated misconceptions about how conception without condomless sex alters paternity.
“The syringe is bad because if I use syringe, is this my baby or is it the syringe's 
baby?” [32-year-old male, HIV+, 001]
“Education before would be very important–getting everyone on the same page. 
Men don't want to be robbed of our manlihood. It's not going to be our baby, it is 
like it's someone else's.” [Male of unknown age, HIV+, FGD]
To HIV-negative men and HIV-positive women however, acceptability was much higher and 
cultural concerns less pronounced.
“I would use the syringe as long as I would get a baby and if I wouldn't get the 
virus. The most important thing is to have a baby and remain HIV-negative, how 
the baby is done is not important.” [40 year-old male, HIV-, 002]
“I think we would do it–my partner would. The main thing is to maintain the 
negative status of the other partner. They should be focusing on their safety and not 
on the traditional way.” [31-year-old female, HIV+, 005]
Acceptability was driven by an understanding of what self-insemination means for paternity, 
as well as knowledge of how to apply the method. Men commonly expressed concerns of 
hurting their partner but were open to having the female partner insert the syringe herself. 
The importance of education was highlighted by men as critical for uptake.
“For me to do it? No. Every time I look at her I'd go blind. When you step on a 
bottle you don't want to take it out. I wouldn't want to hurt her–putting a syringe in 
her I don't think I could do it, so she could do it.” [39-year-old male, HIV-, 003]
In general, condomless sex limited to the fertile period in the presence or absence of ARV-
based strategies was a cause for concern. Although women noted that HIV-negative men 
would prefer sex without a condom or a syringe, messages of the importance of condom use 
had been absorbed by most participants and condomless sex was viewed with skepticism and 
even incorrect information.
“[Condomless sex] is not safe, even if the viral load is low, condoms only.” [Female 
of unknown age, HIV+, FGD]
“I heard that the chances of me getting sick are higher if we have unprotected sex, 
than of him getting infected.” [Female of unknown age, HIV+, FGD]
Preferences between ARV-based and non ARV strategies
Participants were split in their preferences between ARV-based and non ARV-based 
prevention strategies (Table 2), highlighting the diversity in views. In general, self-
insemination was preferred over PrEP if the male partner was uninfected and the female 
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partner infected due to total elimination of HIV transmission risks and absence of side 
effects.
“I don't like pills because of side effects. The syringe would be easier than taking 
pills every day.” [24-year-old male, HIV-, 009]
“I think the syringe is better [than ARVs] because you can't get infected.” [Male of 
unknown age, HIV-, FGD]
“The HIV-negative person would not agree to take ARVs but will agree to use a 
syringe, because they are not sick. They might consider in-vitro fertilization….I 
don't think I would have sex with an HIV-negative man, it is risky and I wouldn't 
want to infect him. I would prefer to use the syringe.” [34-year-old female, HIV+,
006]
“I will choose syringe. But if my partner was positive and I was negative I would 
not take ARVs. I am only taking ARVs because I don't have any choice.” [31-year-
old female, HIV+, 005]
However other men noted they preferred PrEP with condomless sex as it is more “natural” 
and easier to implement.
“Pills (ARVs) would be better. I would prefer to do it naturally.” [32-year-old male, 
HIV+, 001]
“[Regarding manual self-insemination] People will call it insanity. But I guess this 
is no problem. But just I'm afraid of hurting her. The pill is easier!” [39-year-old 
male, HIV- 003]
The only respondent with experience using the method preferred pills. However he had only 
obtained one syringe which required cleaning prior to each use and found self-insemination 
tedious and frustrating. Although he and his partner successfully conceived using this 
method, when asked if he would use the method for future conception, he indicated that he 
would not use self-insemination again.
Among discordant couples where the woman was uninfected, ARV-based strategies were 
typically preferred. Motivation to use ARV-based prevention strategies did not seem to be 
driven by fear of HIV acquisition, but centered around concerns of HIV transmission to the 
developing fetus in the event of seroconversion.
“I am not scared to be infected but I am worried about the baby. If I get infected I 
might also infect the baby–this is what I would worry about.” [Female of unknown 
age, HIV-, 007]
Barriers and facilitators to safer conception uptake and adherence to strategies
The majority of HIV-negative participants indicated that they had learned about 
serodiscordance, but many were not fully convinced that discordance was possible. These 
beliefs could reduce motivation to use and adhere to prevention strategies.
“The last time I tested negative was last week, but still I don't believe it because my 
partner is positive. I have tested negative six times and my partner is positive, but 
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sometimes there are false results. I know I am positive. I have sex with an HIV-
positive woman without using a condom, it means I am also HIV-infected.” [40-
year-old male, HIV-, 002]
“The child might get infected, because even though I'm negative, I don't think I'm 
100% negative, if I sleep with someone who is negative I might infect that person.” 
[Female of unknown age, HIV-, 007]
Poor knowledge around fertility and conception was another barrier, potentially reducing the 
efficacy of timed condomless sex and timed manual self-insemination. Women generally 
knew when to expect their menstrual periods but few knew when they were most fertile.
Similarly various men in the FGD demonstrated questions about the viability of conception 
through manual self-insemination.
“How do you make sure it [semen] will stay in without sex?”
“But how will you know how far to put it in? Is there a certain temperature that 
semen needs to be to live? Because it might cool down too much before I put it in.”
“Does she need to be hot or in the mood”?
Despite these barriers, several factors were identified which may facilitate success, chiefly 
high motivation to protect the health of a future baby.
“I would like [a safer conception clinic] to help us have babies born free from HIV. 
I will always feel guilty if my baby will be born HIV-positive because of me. I will 
think I should not have made this baby.” [31-year-old female, HIV+, 005]
Safer conception services may also serve as a mechanism to get partners to test together if 
HIV status has not yet been confirmed for both partners.
“Getting a positive baby is scary but what I hate to think about is the fact that my 
partner may be positive–maybe even knows he is positive, but wants a baby and so I 
am taking a huge risk.” [28-year-old female, HIV-, 013]
Furthermore, the concept of treatment as prevention was well understood in terms of pills for 
the mother for PMTCT as well as post-exposure prophylaxis for situations of known 
occupational or sexual trauma-related exposure.
“What I think is that when a woman is raped she takes post-exposure prophylaxis, 
ARVS, to prevent getting infected. So maybe ARVs could work to prevent infection 
to partner as well. I don't know.” [Female of unknown age, HIV+, FGD]
Discussion
In this study, where South African HIV-positive and negative men and women were asked to 
compare multiple safer conception methods, we observed high acceptability for both ARV-
based and non ARV-based approaches. Preferences for specific methods varied across 
participants and were predominantly influenced by assessment of effectiveness at reducing 
or eliminating risk, concerns over ARV-related side effects, and knowledge about the 
method.
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Despite high willingness to use ARV-based methods, these strategies were not always 
preferred. High motivation to protect the potential fetus and baby and familiarity with early 
initiation of ART for PMTCT may facilitate the uptake of ARV-based safer conception 
methods. Nevertheless, side effects and ARV appropriateness for those who are not sick 
were raised as concerns, which are themes that have also emerged outside of the context of 
safer conception services.17, 18 The perception that ARV use is not ‘normal’ for healthy 
adults may change in the future, as countries are moving in the direction of ART-based 
prevention strategies for a greater number of individuals, including all pregnant women and 
serodiscordant couples as recommended by the World Health Organization, but not currently 
in the South African Department of Health Treatment Guidelines.19-21 Suboptimal retention 
in care as experienced in PMTCT Option B+ programs22 may also occur in the context of 
early ART or PrEP for safer conception if side effects are perceived as too burdensome or 
motivation for ART wanes after peri-conception and pregnancy-related transmission risks 
elapse. Similarly for PrEP, side effects may limit efficacy, which is highly dependent on 
adherence.23-26 In discordant couples in the Partners PrEP study, only 71% of women who 
conceived had active drug detected in plasma at time of pregnancy diagnosis, and drug levels 
were not higher among women who conceived than those who did not conceive, though 
pregnancies may have been unintentional.27 Qualitative data from women participating in 
PrEP studies highlight adherence barriers including participant confusion about ARVs for 
prevention versus treatment, and HIV stigma concerns around being perceived by others as 
HIV-positive if they are taking ARVs.18 Still the limited timeframe for PrEP for conception 
and motivations around PMTCT may facilitate higher adherence. Additionally previous 
qualitative work has cited partner support for PrEP as a facilitator for adherence and support 
is more likely in the context of a couples-based safer conception service.28 When adherence 
to ARV-based safer conception strategies is difficult to achieve, other strategies may play an 
important role.
Preference for home-based insemination was common among HIV-positive women and 
HIV-negative men, but men expressed concerns regarding their manhood, fear of hurting 
their partner, and paternity. Qualitative work from Kenya and Cape Town, South Africa, 
echoed concerns related to masculinity or culture,29, 30 and also raised issues around 
whether the male or female partner should perform the insemination.11 Concerns around the 
cultural acceptability of non-natural conception strategies were also raised in Uganda by 
providers and clients. In this setting awareness of non ARV-based safer conception methods 
was much higher than in our study, however similar themes related to limited knowledge 
about ovulatory periods and the implications of home-based insemination on the health of 
the fetus were raised.31 What emerged in our analysis is that the concerns around self-
insemination were largely fueled by lack of knowledge and low self-efficacy, but that after 
further information men became overwhelmingly interested. This suggests that education 
rather than deep-rooted cultural opposition is a barrier and that uptake of this strategy may 
be high in the context of safer conception counseling and skills building.
Misconceptions around serodiscordance and fertility could also be important barriers to any 
safer conception strategy. Individuals in discordant couples who do not fully believe that 
they are HIV-negative despite testing negative have also been reported by others,32, 33 and 
this fatalism may diminish motivation to adhere to prevention strategies. Poor understanding 
Schwartz et al. Page 8
Int J STD AIDS. Author manuscript; available in PMC 2017 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
among women about when they are most fertile and among men about the potential for 
conception with self-insemination were also consistently reported. Together these issues 
demonstrate the need for specific counseling within safer conception services around both 
HIV and fertility.
While our findings may not be generalizable to other settings, emerging themes bring 
together many separate ideas found elsewhere. Furthermore, high uptake of self-
insemination and low uptake of PrEP in our on-going safer conception service developed 
through this formative work support the findings of this qualitative analysis.14 Lack of audio 
recording may have limited participant probing and resulted in loss of some information. 
Another limitation of this study is that few HIV-positive participants were ART-naïve, 
limiting the extent of in-depth analysis around the acceptability of early ART initiation. 
Strengths of the study were that multiple safer conception methods were compared and 
patients were specifically asked to indicate their reasons behind preferences for specific 
approaches.
Together these findings indicate a strong education and counseling component of couples 
will be required for effective safer conception services. Training of providers will also be 
required to ensure service availability as well as uniform messaging about fertility and safer 
conception. Providers will need to offer multiple strategies instead of a following single 
algorithm, such that couples can choose a strategy based on a variety of personal and 
relationship-based preferences. Adherence to strategies will require monitoring and support 
services. Providers should also be aware that adjustment of approaches may be necessary to 
optimize HIV prevention and pregnancy outcomes.
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Table 1
Patient knowledge of safer conception methods (SCM)
SCM Knowledge Summary Illustrative Quotes
Overall knowledge • Generally low and primarily limited to 
cursory understanding of assisted 
reproductive technologies
• Concerns frequently expressed about the 
dangers of HIV transmission and 
reinfection related to condomless sex 
while trying to conceive
“I have not heard of ways. I have heard only of 
in-vitro fertilization [to reduce risks] but not 
sure if I know everything.” [34-year-old 
female, HIV+, 006]
“I don't know of any method. The only thing I 
know is that they should use condoms.” [44-
year-old female, HIV-, 012]
“What I've heard is that you are not supposed 
to have sexual intercourse – unprotected – if 
HIV+ because it is bad for your health and 
your viral load will go up.” [Male, HIV+, 
FGD]
“I read from a magazine that ARVs reduce the 
risk but I don't have enough information on 
that regards. There was also information about 
sperm donors but I am not sure if I understood 
well what it was about.” [31-year-old female, 
HIV+, 005]
Knowledge of 
antiretroviral-based 
strategies for prevention 
or or manual self-
insemination
• High knowledge of ARVs to prevent 
mother-to-child transmission of HIV
• Mixed awareness on the efficacy of 
ARVs to prevent horizontal transmission
• Majority of patients had not heard of 
manual self-insemination as a safer 
conception method
“I know that ARVs prevent transmission to the 
baby, but I have never heard of self-
insemination or any other approach.” [36-
year-old female, HIV+, 004]
“ARVs [for the HIV-positive partner] can't 
prevent transmission – there is a risk because 
he's not positive and he's not on ARVs 
[himself].” [Female, HIV+, FGD]
“ARVs don't prevent HIV they are only 
prolonging life. It stops it a bit, but never all 
and only for the time being. There is no way 
to make a baby with this. I have never heard of 
self-insemination, only in-vitro fertilization.” 
[40-year-old male, HIV-, 002]
“I heard that if you're on ARVs, they reduce 
the risk. But I am not sure of other methods. I 
heard one patient talking about the syringe 
method here in the clinic and she explained it 
like she had done it before.” [32-year-old 
male, HIV+, 011]
“I don't have any information and I don't know 
how ARVs work as I don't take them. But I 
think it could be true [that ARVs reduce 
transmission risk] based on my experience.” 
[Female, HIV-, 007]
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